Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's
Authors:
- 1 April 2015
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 71, 146-152
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Probing the α‐Helical Structural Stability of Stapled p53 Peptides: Molecular Dynamics Simulations and AnalysisChemical Biology & Drug Design, 2010
- Acetylcholinesterase: ‘classical’ and ‘non-classical’ functions and pharmacologyCurrent Opinion in Pharmacology, 2005
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database ScreeningJournal of Medicinal Chemistry, 2004
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking AccuracyJournal of Medicinal Chemistry, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on PeptidesThe Journal of Physical Chemistry B, 2001
- GalantamineDrugs, 2000
- Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic LiquidsJournal of the American Chemical Society, 1996
- LIGPLOT: a program to generate schematic diagrams of protein-ligand interactionsProtein Engineering, Design and Selection, 1995
- Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition statesChemical Reviews, 1987